News Snapshot:
Chinese COVID-19 vaccine shows promising trial results: research paper August 16, 2020 A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co., Ltd. (Sinopharm) in Beijing, capital of China, April 10, 2020. (Xinhua/Zhang Yuwei) BEIJING, Aug. 16 (Xinhua) – An inactivated COVID-19 vaccine candidate developed by China is safe and generates an immune response, according to data from clinical trials published in The Journal of the American Medical Association this week. The research paper provided an interim analysis of the phase-1 and phase-2 clinical trials of an inactivated...
